Community/Retail

Motivational interviewing is an evidence-based method of communicating with patients who are ambivalent or resistant to change for the sake of their health.

The value proposition for point-of-care testing in the pharmacy is extensive, as pharmacies can provide a convenient, accessible, and cost-saving alternative for patients.

Women Pharmacist Day takes place October 12th, 2022.

Teva Pharmaceutical Industries announced that fremanezumab can successfully reduce 2 common migraine comorbid symptoms—anxiety and depression.

As individuals in a society, all people have implicit, or unconscious, beliefs that they have been socialized to hold; however, health care professionals’ implicit biases can impact patients’ lives.

Pharmacy Times will be spotlighting pharmacists throughout the month of October to recognize their contributions to the health care field.

Phoenix-area Walgreens pharmacist Matthew Pruitt earns top honor as 2022 Pharmacist of the Year.

Empagliflozin has been found to lower the risk of death due to cardiovascular events and the number of first and recurrent heart failure hospitalizations.

Indicated for the management of mild, moderate, and severe Alzheimer disease and dementia symptoms, the donepezil transdermal system (Adlarity; Corium) delivers donepezil hydrocholoride through the skin and is recommended at an initial dosage of 5 mg per day.

Douglas Hoey, CEO of NCPA, discusses NCPA's Annual Convention 2022, which will be held in Kansas City, Missouri from October 1 to October 4.

This month's generic product news features clorazepate dipotassium tablets, exemestane tablets, and paliperidone extended-release tablets.

Willoughby hopes on a global standpoint that every chronic condition patient has access to a support team that is there to provide care.

The incremental use of drug combinations could prevent hospitalizations from heart failure among those who have higher ejection farction, a subgroup that struggles with insufficient data on treatments.

Dupilumab is the first and only medicine approved specifically for the treatment of prurigo nodularis in the United States.

FDA revises emergency use authorization to grant prescribing authority for Pfizer’s Paxlovid antiviral treatment for COVID-19.

Research suggests that HIV risk-reduction interventions could help adolescent males who are attracted to the same sex—and part of a minority ethnic and racial group—decrease HIV-risk sexual behaviors in the short-term.

New research suggests patients with type 2 diabetes who have elevated glycated hemoglobin levels, even when on metformin, could benefit by adding glucose-lowering glargine.

With a simple intervention, pharmacists came off as compassionate and caring while their efficacy in treating patients improved.

This month's Rx product news features Qulipta, Eylea, and Paxlovid.

This month's OTC cases features anemia.

Continuous glucose monitors eliminate the need for frequent fingerstick use and carrying blood glucose monitoring supplies.

The forthcoming strategic plan will be focused on guiding future NIH research efforts to improve the health of all women throughout the life course.

Pharmacists play an important role in the recovery journey for patients who decide medication assisted treatment is right for them.

Appointment-based models are typically most effective when all pharmacy team members participate.

Lawsuit asserts physician, pharmacist negligence in patient’s fatal overdose after she received alprazolam, oxycodone, oxymorphone.

We spoke with Brandon Dyson, PharmD, BCOP, co-founder of TL;DR Pharmacy, to hear about this unique resource for pharmacy students.

On this week's episode, host Joanna speaks with Charlie Conway, PhD, chief scientific officer at Biohaven Pharmaceuticals about migraine function, care, and treatment.

Investigators combine research discovery with technological development to determine whether the role of genomics in nephrology should remain with subspecialists or be integrated into general nephrology.

Patients could have a better immune response against the omicron variant of COVID-19 with a second booster of the bivalent mRNA-1273.214 vaccine at a 50 μg dose.

Omidenepag isopropyl ophthalmic solution (Omlonti) eye drops are indicated to reduce elevated intraocular pressure in patients with primary open-angle glaucoma or ocular hypertension.